V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20213346 | 20079804 | 1.61 | 74 | 03 | 2019-04-02 | 2019-04-23 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | IMATINIB | 101318273 |
| 20213347 | 20079805 | 1.62 | 86 | Curative (C) | 2018-01-04 | 2018-01-20 | Fluorouracil+Mitomycin+RT (Bladder) | N | null | FLUOROURACIL + MITOMYCIN + RT | 100372960 |
| 20213349 | 20079806 | 1.75 | 83 | Palliative (P) | 2019-11-15 | 2019-11-15 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101740453 |
| 20213351 | 20079807 | 1.61 | 75.5 | Palliative (P) | 2017-08-11 | 2017-08-12 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101117856 |
| 20213353 | 20079808 | null | null | null | 2018-04-14 | 2018-05-22 | LANREOTIDE | 02 | null | LANREOTIDE | 100295037 |
| 20213354 | 20079809 | 1.68 | 77.9 | Palliative (P) | 2020-12-15 | 2021-01-11 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100227183 |
| 20213356 | 20079810 | null | 55.2 | null | 2017-06-03 | 2017-06-09 | LANREOTIDE | 02 | null | LANREOTIDE | 100940057 |
| 20213357 | 20079811 | 1.77 | 65.5 | Curative (C) | 2018-11-04 | 2018-11-04 | FLUOROURACIL + MITOMYCIN + RT | N | Y | FLUOROURACIL + MITOMYCIN + RT | 100388009 |
| 20213359 | 20079812 | 1.65 | 68.1 | Disease modification (D) | 2018-09-26 | 2018-10-11 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 100616159 |
| 20213362 | 20079813 | 1.8 | 81.3 | null | 2022-03-02 | 2022-03-02 | LANREOTIDE | 2 | N | LANREOTIDE | 100735150 |
| 20213363 | 20079814 | 1.73 | 67.5 | Curative (C) | 2018-08-14 | 2018-08-22 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 101627681 |
| 20213364 | 20079815 | 1.66 | 71.9 | null | 2018-07-30 | 2018-08-16 | LANREOTIDE | 02 | N | LANREOTIDE | 100536126 |
| 20213365 | 20079816 | 1.49 | 57.5 | Palliative (P) | 2019-05-14 | 2019-06-04 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | TRIAL | 100959385 |
| 20213366 | 20079817 | 1.71 | 69.45 | Palliative (P) | null | 2013-01-01 | null | null | N | TRIAL | 100456776 |
| 20213367 | 20079818 | 1.61 | 97.9 | Curative (C) | 2016-12-24 | 2017-01-03 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101317963 |
| 20213369 | 20079819 | null | 0 | Curative (C) | 2017-12-21 | 2018-01-11 | Imatinib 400mg | 02 | N | IMATINIB | 100938479 |
| 20213370 | 20079820 | 1.7 | 89 | Neo-adjuvant (N) | null | 2017-08-14 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | TRIAL | 101854536 |
| 20213371 | 20079821 | 1.78 | 93.2 | Curative (C) | 2018-03-12 | 2018-03-16 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 100859083 |
| 20213372 | 20079822 | 1.77 | 51.5 | Palliative (P) | 2017-05-25 | 2017-05-25 | IMATINIB | 02 | N | IMATINIB | 100193970 |
| 20213373 | 20079823 | 1.73 | 82.2 | null | 2018-05-14 | 2018-05-27 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 100234632 |
| 20213374 | 20079824 | 1.61 | 75.9 | Palliative (P) | 2017-02-21 | 2017-02-27 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101507096 |
| 20213375 | 20079825 | 1.69 | 102.4 | Curative (C) | 2018-11-10 | 2018-11-15 | Cape+Cisplatin+Trastuzumab Load | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100790360 |
| 20213376 | 20079826 | 1.72 | 0 | Palliative (P) | 2020-03-04 | 2020-03-18 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100153452 |
| 20213377 | 20079827 | 1.63 | 71 | Palliative (P) | 2017-08-16 | 2017-09-20 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100973097 |
| 20213378 | 20079828 | 1.77 | 51 | null | 2019-01-16 | 2019-01-16 | Cape+Cisplatin+Trastuzumab Load | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100474028 |
| 20213379 | 20079829 | 1.91 | 72.3 | Radical (R) | 2018-04-07 | 2018-04-24 | FLUOROURACIL + MITOMYCIN + RT | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100442120 |
| 20213380 | 20079830 | 1.8 | 99.3 | Palliative (P) | 2018-04-30 | 2018-05-07 | HCX | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100668456 |
| 20213381 | 20079831 | null | null | Curative (C) | 2017-12-24 | 2018-01-04 | FLUOROURACIL + MITOMYCIN + RT | N | N | FLUOROURACIL + MITOMYCIN + RT | 100749206 |
| 20213382 | 20079832 | 1.76 | 71.5 | Palliative (P) | 2019-08-12 | 2019-08-14 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101389579 |
| 20213383 | 20079833 | 1.66 | 68 | null | 2019-10-10 | 2019-10-31 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 101808647 |
| 20213384 | 20079834 | 1.74 | 0 | Palliative (P) | 2017-01-07 | 2017-01-14 | GO2 TRIAL | N | N | TRIAL | 101250466 |
| 20213386 | 20079836 | 1.77 | 80.5 | Palliative (P) | 2018-03-29 | 2018-03-29 | Trial Unspecified | 01 | N | TRIAL | 100927514 |
| 20213387 | 20079837 | 1.61 | 79.8 | null | null | 2018-03-03 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101168547 |
| 20213388 | 20079838 | 1.66 | 87 | Palliative (P) | 2016-03-07 | 2016-03-07 | Cape+Cisplatin+Trastuzumab Load | 02 | N | IMATINIB | 100650981 |
| 20213389 | 20079839 | 1.7 | 59.11 | Palliative (P) | 2017-11-06 | 2017-11-16 | Trial Unspecified | Y | N | TRIAL | 100255951 |
| 20213390 | 20079840 | 1.55 | 72 | Curative (C) | 2016-10-06 | 2016-10-18 | FLUOROURACIL + MITOMYCIN + RT | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100070068 |
| 20213392 | 20079842 | 1.55 | 75.5 | Curative (C) | 2018-07-23 | 2018-07-27 | HCX | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 100569576 |
| 20213394 | 20079844 | 1.6 | 90 | Palliative (P) | 2017-05-08 | 2017-05-08 | Trial Unspecified | Y | N | TRIAL | 100156079 |
| 20213395 | 20079845 | 1.84 | 97 | Curative (C) | 2017-04-07 | 2017-04-07 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100592217 |
| 20213396 | 20079846 | 1.74 | 72 | Neo-adjuvant (N) | 2019-01-21 | 2019-01-27 | Cape+Cisplatin+Trastuzumab Load | 02 | N | TRIAL | 101269853 |
| 20213397 | 20079847 | 1.64 | 86 | 03 | 2017-02-16 | 2017-02-20 | Cape+Cisplatin+Trastuzumab Load | 02 | N | IMATINIB | 100833861 |
| 20213398 | 20079848 | 1.77 | 91 | Curative (C) | 2016-08-22 | 2016-08-22 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100769443 |
| 20213399 | 20079849 | 1.58 | 74 | Palliative (P) | 2019-04-22 | 2019-04-29 | Cape+Cisplatin+Trastuzumab Load | 02 | N | IMATINIB | 101834300 |
| 20213400 | 20079850 | 1.72 | 97 | Palliative (P) | 2017-08-02 | 2017-08-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100372754 |
| 20213401 | 20079851 | 1.64 | 63 | null | 2021-08-25 | 2021-08-29 | LANREOTIDE | 02 | null | LANREOTIDE | 100478549 |
| 20213402 | 20079852 | null | null | Palliative (P) | 2019-03-16 | 2019-04-08 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | LANREOTIDE | 101523000 |
| 20213403 | 20079853 | 1.9 | 91 | Palliative (P) | 2017-03-25 | 2017-03-26 | GO2 TRIAL | N | N | TRIAL | 100123776 |
| 20213405 | 20079854 | null | 51.55 | Palliative (P) | 2018-04-30 | 2018-05-04 | LANREOTIDE | 02 | N | LANREOTIDE | 101118456 |
| 20213406 | 20079855 | null | 51 | Palliative (P) | 2017-03-10 | 2017-03-10 | LANREOTIDE | 02 | N | LANREOTIDE | 101188328 |
| 20213408 | 20079856 | 1.53 | 120 | Adjuvant (A) | 2016-03-15 | 2016-03-17 | HCX | 02 | N | IMATINIB | 100778770 |